Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022)
Neuroone Medical Technologies' (NMTC) quarterly Non-Current Deferred Tax Liability came in at $140538.0 in Q3 2022, up 118.94% YoY from $64189.0 in Q3 2021, and up 118.94% on a QoQ basis from $64189.0 in Q3 2021.
Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $140538.0 in Q3 2022.
- Quarterly Non-Current Deferred Tax Liability rose 118.94% year-over-year to $140538.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $140538.0 (up 118.94% YoY) and the FY2022 annual result came in at $140538.0, up 118.94% from the prior year.
- Non-Current Deferred Tax Liability rose to $140538.0 in Q3 2022, from $64189.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $140538.0 in Q3 2022 to a low of $64189.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 19.89 Mn | 17.84 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 140,538.00 |
| Sep 30, 2022 | 140,538.00 |
| Sep 30, 2021 | 64,189.00 |
| Sep 30, 2021 | 64,189.00 |